HomeNewslettersHematopoiesis NewsSafety and Efficacy of Autologous Hematopoietic Stem-Cell Transplantation with Low-Dose Cyclophosphamide Mobilisation...
Safety and Efficacy of Autologous Hematopoietic Stem-Cell Transplantation with Low-Dose Cyclophosphamide Mobilisation and Reduced Intensity Conditioning Versus Standard of Care in Refractory Crohn’s Disease (ASTIClite)
Participants were centrally randomly assigned, 2:1, to either HSCT with a reduced dose of cyclophosphamide (intervention group) or standard care (control group).